Active substancePalm Creeping Fruit ExtractPalm Creeping Fruit Extract
Similar drugsTo uncover
  • Palprostes®
    capsules inwards 
    TAD Pharma GmbH     Germany
  • Permixon
    capsules inwards 
  • Prostamol® Uno
    capsules inwards 
       
  • Prostaplant
    capsules inwards 
  • ProstatOff
    capsules inwards 
    VIFITEH, CJSC     Russia
  • Dosage form: & nbspcapsules
    Composition:

    Composition per one capsule:

    Active substance:

    Spirituous extract of palm fruits creeping (9-11: 1) - 320 mg

    Excipients:

    Capsule shell: gelatin succinylated - 120,20 - 141,11 mg, glycerol - 45,20 - 53,07 mg, purified water - 7,98 - 9,36 mg, titanium dioxide - 0,65 - 0,77 mg, iron dye oxide black - 0,78 - 0,92 mg, dye crimson [Ponso 4R] - 1.05 - 1.23 mg.

    Description:

    Oval, soft, gelatin capsules with a light-tight two-tone red-black shell. Contents of the capsule: a greenish-brown liquid with a characteristic odor.

    Pharmacotherapeutic group:A remedy for benign prostatic hyperplasia of plant origin
    ATX: & nbsp

    G.04.C.X   Other drugs for the treatment of benign prostatic hyperplasia

    G.04.C.X.02   Palm Creeping Fruit

    Pharmacodynamics:

    Extract of palm fruit creeping (Serenoa repens) has antiproliferative antiandrogenic, anti-inflammatory, and anti-edematous effects, which are selectively manifested at the level of the prostate gland.In this case, the drug does not affect the level of sex hormones in the blood plasma, does not affect the potency and libido and does not change the level of prostate-specific antigen in the blood plasma.

    Local antiproliferative effect of the drug is decreased activity of growth factors (especially the epidermal and fibroblastic), inhibition of binding of prolactin receptors and subsequent signal transduction processes violation in prostate cells and accelerate the apoptosis of prostate cells, which is reflected in the inhibition of growth of the prostate gland.

    Mechanism topical antiandrogenic action due to inhibition of the synthesis of DHT from testosterone (by inhibiting the enzyme 5-alpha reductase type I and II) and its fixation to the cytosolic receptor of prostate cells, which prevents the penetration of the hormone to the nucleus. As a result, protein synthesis is reduced.

    The mechanism of local anti-inflammatory effect is due to the fact that the fruit extract creeping palm (Serenoa repens) inhibits the activity of phospholipase A2, 5-lipoxygenase and the release of arachidonic acid, thereby reducing the synthesis of prostaglandins and leukotrienes which are mediators of inflammation. Prostamol® Uno reduces capillary permeability and vascular stasis, reduces swelling and inflammation in the prostate, eliminates the compression of the neck of the bladder and urinary canal, improving urodynamics.

    Thus, the drug Prostamol® Uno contributes, on the one hand, to a decrease in the severity of the pathological symptoms of benign prostatic hyperplasia (dysuria, pollakiuria, nocturia, painful sensations and feelings of stress during urination, incomplete emptying of the bladder), increased volume and strength of urination. On the other hand, against the background of the use of the drug, further growth and increase in the volume of the prostate gland is slowed down.

    Pharmacokinetics:

    Extract of palm fruit creeping (Serenoa repens) is rapidly absorbed. After oral administration, the maximum concentration in the plasma is reached after about 1.5 hours.

    Indications:

    Benign prostatic hyperplasia (I and II stages).

    Elimination of dysuric symptoms (upset urination, night pollakiuria, pain syndrome, etc.) with chronic prostatitis.

    Contraindications:

    Individual intolerance to the components of the drug.

    Dosing and Administration:

    The drug is Prostamol® Uno use 1 capsule (320 mg) once a day at the same time, after eating, without chewing, squeezed with enough liquid. The duration of treatment is not limited in time. The recommended duration of the course of therapy is at least three months.

    Side effects:

    Allergic reactions to the drug components are possible. In rare cases - discomfort from the gastrointestinal tract: nausea, heartburn (when taken on an empty stomach).

    Overdose:

    Cases of overdose of Prostamol® Uno is not registered.

    Interaction:

    Interactions with other drugs have not been identified.

    Special instructions:

    Prostamol® Uno reduces the severity of symptoms with an enlarged prostate gland, without eliminating its increased size. Prevents further proliferation of prostate tissue. Prostamol® Uno does not affect sexual function.

    Effect on the ability to drive transp. cf. and fur:Prostamol® Uno does not affect the ability to drive vehicles and work requiring increased concentration of attention.
    Form release / dosage:

    Capsules of 320 mg.

    Packaging:

    15 capsules per blister (PVC / PVDC / aluminum foil).

    For 1, 2, 4 or 6 blisters with instructions for use in a cardboard bundle.

    Storage conditions:

    Store at a temperature not exceeding 25 ° C.

    Keep the medicine out of the reach of children!

    Shelf life:

    3 years.

    Do not use the product after the expiry date printed on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N012255 / 01
    Date of registration:29.12.2010 / 16.06.2014
    Manufacturer: & nbsp
    Information update date: & nbsp14.08.2015
    Illustrated instructions
      Instructions
      Up